View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Laboratorios Inibsa
14 October 2013

Laboratorios Inibsa will Produce Injectable for the French Market

CDM Lavoisier has chosen Laboratorios Inibsa as the best option for the pharmaceutical injectable manufacturing.

After several months of negotiations both Pharmaceutical Companies have signed a long-term contract for injectable ampoules for the French market.

The agreement includes the improvement of the CDM Lavoisier products quality with a longer shelf-life and updates the ampoule format from preprinted ones to labelled ampoules.

Yves Lambert, technical manager of CDM Lavoisier Laboratories, said: "After discussion and benchmarking we have chosen to establish a long term partnership with Inibsa due to the quality of the documentation provided, the quality of the equipment and the professionalism of the Inibsa team."

 

Inibsa's constant pursuit of excellence, along with an investment policy aimed at providing the highest technological standards, means we can offer our clients a wide...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology